Ifp Advisors, Inc Selecta Biosciences Inc Transaction History

Ifp Advisors, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$0.96 - $1.6 $1,296 - $2,160	-1,350 Reduced 2.87%	45,760 $550,000
Q3 2022 Nov 08, 2022	BUY	$1.33 - $2.6 $20,694 - $40,456	15,560 Added 49.32%	47,110 $566,000
Q2 2022 Sep 06, 2022	BUY	$0.67 - $1.4 $21,138 - $44,170	31,550 New	31,550 $379,000
Q2 2022 Aug 12, 2022	SELL	$0.67 - $1.4 $21,138 - $44,170	-31,550 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.23 - $3.31 $38,806 - $104,430	31,550 New	31,550 $38,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.